Schwannomatosis Awards

The Children’s Tumor Foundation (CTF) is focused on ending neurofibromatosis (NF) through research. To date CTF has committed over $35M to NF research, ranging from preclinical drug testing to clinical research and a national NF Clinic Network.

Schwannomatosis is the rarest form of NF, affecting 1:40,000 persons and causing peripheral nerve tumors and unmanageable pain.

In 2007 a candidate schwannomatosis gene, INI-1/Smarc-B1/Snf-5 was identified. Harnessing this discovery, over the past several years CTF has i) convened a series of Schwannomatosis Workshops to identify priorities for advancing schwannomatosis research; and ii) funded schwannomatosis research totaling over $1.3 million since 2007. Results from this include the first schwannomatosis mouse models, utilizing these for preclinical drug trials, advancing schwannomatosis genetics, and establishing an international Schwannomatosis Database.

CTF is offering 2014 Schwannomatosis Awards of up to $75,000 each.
Schwannomatosis Awards may be requested for research in any area of relevance to advancing schwannomatosis research in the following priority areas:

  • Genetics
  • Cell Biology & Translational Research
  • Clinical Research

More details on the above priority areas are provided in the Request for Applications (RFA) which is available for download at the following link:

Schwannomatosis RFA 2014  pdficon small

Due Date: September 1, 2014**

**IMPORTANT: the deadline has been moved to September 1 to accomodate the needs of our researchers. Please disregard the notation of a July 15 deadline on your downloaded application. 

 YOU MUST USE THE LATEST VERSION OF ADOBE READER TO FILL IN, SAVE AND RETURN THE RFA.Click here to download the latest version of Adobe Reader software.

If you have questions please contact

Recent Schwannomatosis Award Recipients

Dr. Marco Giovannini, House Research Institute 
Development of a screening platform for Schwannomatosis therapeutic agents

Dr. Larry Sherman, Oregon National Primate Research Center
Regulation of TRPV1 in sensory neurons by SNF5-null Schwann cells

Dr. Scott R. Plotkin, Massachusetts General Hospital    
Neurotrophin levels in schwannomas and schwannomatosis patients: is there a relationship to chronic pain?

Dr. Laura Papi, House Research Institute            
Exome Sequencing of schwannomatosis genome

Dr. Betty Tyler, Johns Hopkins Medical Instutute
Creating preclinical models of surgery for spinal schwannomas

Contact Us

Children's Tumor Foundation
120 Wall Street, 16th Floor
New York, NY 10005-3904

Phone: 212-344-6633